(Q37472070)

20 August 2017

1 reference

title

Xience V everolimus-eluting coronary stent (English)

1 reference

20 August 2017

3

Patrick W Serruys

1 reference

20 August 2017

2

Yoshinobu Onuma

1 reference

20 August 2017

1

Neville Kukreja

1 reference

20 August 2017

1 May 2009

1 reference

Expert Review of Medical Devices

20 August 2017

1 reference

20 August 2017

6

1 reference

20 August 2017

3

1 reference

20 August 2017

219-229

1 reference

Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty

20 August 2017

1 reference

A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group

21 January 2018

1 reference

A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators

21 January 2018

1 reference

Immunosuppressive drugs for kidney transplantation.

21 January 2018

1 reference

A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization

21 January 2018

1 reference

Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery

21 January 2018

1 reference

Three-year clinical follow-up of the unrestricted use of sirolimus-eluting stents as part of the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry.

21 January 2018

1 reference

Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS).

21 January 2018

1 reference

The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS).

21 January 2018

1 reference

Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients: an evaluation from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) study

21 January 2018

1 reference

Safety of coronary sirolimus-eluting stents in daily clinical practice: one-year follow-up of the e-Cypher registry

21 January 2018

1 reference

Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents.

21 January 2018

1 reference

A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents

21 January 2018

1 reference

Sirolimus-eluting versus uncoated stents in acute myocardial infarction.

21 January 2018

1 reference

Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis

21 January 2018

1 reference

Rapamycin, but not FK-506, increases endothelial tissue factor expression: implications for drug-eluting stent design

21 January 2018

1 reference

Sirolimus accelerates senescence of endothelial progenitor cells through telomerase inactivation

21 January 2018

1 reference

Antiproliferative agents alter vascular plasminogen activator inhibitor-1 expression: a potential prothrombotic mechanism of drug-eluting stents.

21 January 2018

1 reference

Sirolimus-eluting stents associated with paradoxic coronary vasoconstriction

21 January 2018

1 reference

Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation

21 January 2018

1 reference

Sirolimus-eluting stent implantation aggravates endothelial vasomotor dysfunction in the infarct-related coronary artery in patients with acute myocardial infarction

21 January 2018

1 reference

Impaired endothelial vasomotor function after sirolimus-eluting stent implantation.

21 January 2018

1 reference

A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease

21 January 2018

1 reference

Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial.

21 January 2018

1 reference

The unrestricted use of paclitaxel- versus sirolimus-eluting stents for coronary artery disease in an unselected population: one-year results of the Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registry

21 January 2018

1 reference

TAXUS VI 2-year follow-up: randomized comparison of polymer-based paclitaxel-eluting with bare metal stents for treatment of long, complex lesions

21 January 2018

1 reference

Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention.

21 January 2018

1 reference

Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions

21 January 2018

1 reference

Paclitaxel enhances thrombin-induced endothelial tissue factor expression via c-Jun terminal NH2 kinase activation.

21 January 2018

1 reference

Local vascular dysfunction after coronary paclitaxel-eluting stent implantation.

21 January 2018

1 reference

Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study

21 January 2018

1 reference

Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents

21 January 2018

1 reference

Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents

21 January 2018

1 reference

Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up

21 January 2018

1 reference

Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk.

21 January 2018

1 reference

Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries

21 January 2018

1 reference

Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?

21 January 2018

1 reference

Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project.

21 January 2018

1 reference

Incidence and clinical impact of coronary stent fracture after sirolimus-eluting stent implantation.

21 January 2018

1 reference

Usefulness of a cobalt chromium coronary stent alloy.

21 January 2018

1 reference

Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial

21 January 2018

1 reference

SDZ RAD, a new rapamycin derivative: pharmacological properties in vitro and in vivo

21 January 2018

1 reference

Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients

21 January 2018

1 reference

Selective clearance of macrophages in atherosclerotic plaques by autophagy.

21 January 2018

1 reference

Oral everolimus inhibits in-stent neointimal growth

21 January 2018

1 reference

Experimental efficacy of an everolimus eluting cobalt chromium stent.

21 January 2018

1 reference

Endothelial cell recovery between comparator polymer-based drug-eluting stents

21 January 2018

1 reference

Six- and twelve-month results from first human experience using everolimus-eluting stents with bioabsorbable polymer.

21 January 2018

1 reference

Angiographic results of the first human experience with everolimus-eluting stents for the treatment of coronary lesions (the FUTURE I trial).

21 January 2018

1 reference

Effect of everolimus-eluting stents in different vessel sizes (from the pooled FUTURE I and II trials).

21 January 2018

1 reference

Clinical end points in coronary stent trials: a case for standardized definitions

21 January 2018

1 reference

Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial

21 January 2018

1 reference

Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the "real world": the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry

21 January 2018

1 reference

Four-year clinical follow-up after implantation of the endeavor zotarolimus-eluting stent: ENDEAVOR I, the first-in-human study

21 January 2018

1 reference

Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions: clinical and angiographic results of the ENDEAVOR II trial.

21 January 2018

1 reference

Comparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease: a randomized controlled trial.

21 January 2018

1 reference

Angiographic results of the first human experience with the Biolimus A9 drug-eluting stent for de novo coronary lesions.

21 January 2018

1 reference

Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial

21 January 2018

1 reference

A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial

21 January 2018

1 reference

2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERD.09.1

1 reference

20 August 2017

1 reference

PubMed ID

19419279